Every Form 4 that H.B. Fuller Company (FUL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow FUL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FUL filings page.
H.B. Fuller senior vice president Joao Magalhaes received 293 performance stock units on January 20, 2026. These units convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026, based on the company achieving return on invested capital at 80% of the target level. Following this grant, he directly holds 3,285 shares of common stock plus multiple blocks of employee stock options with exercise prices between $45.05 and $77.72 and expiration dates ranging from January 2027 to February 2035, as well as several tranches of restricted stock units that also convert into common shares on a 1-for-1 basis. The filing reflects equity compensation and existing holdings, with no reported stock sales.
H.B. Fuller Executive Vice President James J. East reported an equity award and updated holdings. On January 20, 2026, he received 1,739 performance stock units, which convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026. This amount reflects the company achieving its return on invested capital payout at 80% of the target level.
The Form 4 also lists his existing equity-based compensation, including multiple employee stock option grants, phantom units and restricted stock units that each convert into common shares on a 1-for-1 basis, with several awards vesting in three annual installments of 33%, 33% and 34%. East holds common stock directly and through a 401(k) plan, and the filing reflects an award and updated positions rather than any sale of shares.
H.B. Fuller senior vice president of global R&D, Du Xinyu, reported an equity award in company stock. On January 20, 2026, Du acquired 374 performance stock units, each convertible into one share of common stock and scheduled to vest on January 24, 2026, reflecting an 80% payout of a return-on-invested-capital target.
The filing also shows Du directly holds 2,254 shares of common stock, along with multiple employee stock options and restricted stock units covering several thousand additional shares at exercise prices between $48.35 and $77.72, with expiration dates running through 2035.
H.B. Fuller Executive VP and CFO John J. Corkrean received 2,943 performance stock units on January 20, 2026, at a stated price of $0.0000 per unit. These performance stock units convert into common stock on a 1-for-1 basis and represent a contingent right to receive H.B. Fuller common stock on the vesting date of January 24, 2026, based on return on invested capital payout at 80% of the target level. Following the reported transactions, he directly beneficially owned 54,646 shares of common stock and held a range of employee stock options, phantom units, and restricted stock units tied to H.B. Fuller common stock.
H.B. Fuller senior vice president Heather Campe, Sr. VP, International Growth, received 1,415 performance stock units on January 20, 2026. These units convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026, reflecting achievement of return on invested capital at 80% of the target level.
After this grant, Campe directly holds 22,334.0782 shares of H.B. Fuller common stock, plus a range of vested and unvested employee stock options, restricted stock units, performance stock units and phantom units that each represent additional contingent rights to receive H.B. Fuller common shares under the company’s equity and deferred compensation plans.
H.B. Fuller Executive VP and CFO John J. Corkrean reported an acquisition of 200.18 Phantom Units of the company’s common stock on January 16, 2026. These Phantom Units were credited at a reference price of $60.54 per unit and now total 28,248.05 units, which convert into common stock on a 1-for-1 basis under the deferred compensation plan. The filing also shows he directly holds 54,646 shares of common stock, along with multiple fully vested and time-vesting employee stock options and restricted stock units that each relate to H.B. Fuller common stock.
H.B. Fuller senior vice president Heather Campe reported a new equity award and updated her holdings in company stock and related awards. On January 16, 2026, she acquired 35.81 Phantom Units at a reference price of $60.54 per unit, which track H.B. Fuller common stock and convert into shares on a 1-for-1 basis under a deferred compensation plan.
Following this award, she directly holds 22,334.0782 shares of H.B. Fuller common stock, with the amount including shares from a dividend reinvestment plan. She also directly holds 5,297.82 Phantom Units, several fully vested employee stock options and options that vest over three annual installments, and multiple restricted stock unit awards that each convert into common stock on a 1-for-1 basis and vest in three yearly tranches.
H.B. Fuller Company insider activity: A company officer, the VP, Corporate Controller, reported equity transactions dated 12/31/2025. The filing shows 257 phantom units converting into common stock at a price of $59.46, with 73 shares withheld to cover taxes, leaving 15,283.307 shares of common stock beneficially owned directly afterward. The officer also reports 2,824.63 phantom units that convert into common stock on a 1-for-1 basis under a deferred compensation plan, along with multiple fully vested employee stock options and additional options and restricted stock units that vest in annual installments, all ultimately settling in H.B. Fuller common stock.
H.B. Fuller’s Executive Vice President and Chief Financial Officer reported updated ownership of company equity. Following the latest reported activity dated 01/02/2026, the officer directly holds 54,646 shares of H.B. Fuller common stock.
The filing also lists various derivative equity holdings, including 200.84 phantom units that reference an equal number of common shares, as well as multiple employee stock options and restricted stock units with different exercise prices, vesting schedules, and expiration dates. These positions together outline the executive’s mix of direct stock ownership and long‑term incentive awards tied to H.B. Fuller’s common shares.
H.B. Fuller Company executive reports updated stock and equity holdings. A senior vice president for international growth at H.B. Fuller (ticker FUL) filed a report covering company stock, phantom units, stock options, and restricted stock units as of 01/02/2026.
The executive now beneficially owns 22,334.0782 shares of common stock directly, a figure that includes shares acquired through a dividend reinvestment plan. The filing also shows an acquisition of 35.93 phantom units, which are tied 1-for-1 to common stock and credited with dividend equivalents.
In addition, the officer holds multiple fully vested and time-vesting employee stock options with exercise prices ranging from $51.89 to $77.72, plus several tranches of restricted stock units that convert into common shares on a 1-for-1 basis and vest in three annual installments beginning on the dates shown.
H.B. Fuller Company officer files insider transaction report. A senior vice president for international growth reported equity holdings and a new transaction dated 12/19/2025. Following the reported activity, the insider directly beneficially owns 22,334.0782 shares of H.B. Fuller common stock.
The filing shows 36.2 phantom units acquired at $59.89 per unit, which convert into common stock on a 1-for-1 basis, bringing total phantom units beneficially owned to 5,226.08. The report also lists multiple employee stock options with exercise prices ranging from $51.89 to $77.72 and expiration dates from 01/25/2028 to 01/27/2035, as well as time-vested restricted stock units that also convert to common stock on a 1-for-1 basis.
H.B. Fuller’s Executive Vice President and Chief Financial Officer reported updated equity ownership. The filing shows he directly holds 54,646 shares of H.B. Fuller common stock. On 12/19/2025, he acquired 157.38 phantom units at a conversion price of $0.0000, each tied on a 1-for-1 basis to H.B. Fuller common stock under the company’s deferred compensation plan.
The report also lists a range of previously granted employee stock options, all on common stock, with exercise prices from $45.05 to and expirations between 01/24/2027 and 01/27/2035. Some options are already 100% vested, while others vest in three annual installments of 33%, 33%, and 34%. In addition, he holds restricted stock units that convert into common shares on a 1-for-1 basis and generally vest in similar three-year annual tranches, with amounts reflecting additional units from dividend reinvestment features.
H.B. Fuller Company’s Executive Vice President and Chief Financial Officer reported updated equity holdings in a Form 4 insider filing. On 12/05/2025, the officer acquired 162.09 phantom units, which are derivative securities that convert into an equal number of H.B. Fuller common shares on a 1-for-1 basis under the company’s deferred compensation plan. The filing shows these units are tied to the company’s stock price, here referenced at $58.15 per share, and are generally settled upon certain termination events or an earlier date elected by the participant, subject to legal holding periods.
Following the reported transactions, the officer beneficially owns 54,646 shares of common stock directly, along with a portfolio of employee stock options and restricted stock units. The options have exercise prices ranging from $45.05 to $77.72 per share with expiration dates extending through 2035, and several grants are already fully vested. The filing also lists restricted stock units that vest in three annual installments and convert into common stock on a 1-for-1 basis, some of which include additional units earned through dividend reinvestment features.
H.B. Fuller Company executive reports updated equity holdings and awards. A senior vice president filed a Form 4 for activity dated 12/05/2025. Following the reported transactions, the executive directly beneficially owns 22,316.23 shares of H.B. Fuller common stock, an amount that includes shares acquired through a dividend reinvestment plan.
The filing shows acquisition of 37.28 phantom units on 12/05/2025, which convert into common stock on a 1‑for‑1 basis and are linked to a deferred compensation plan. After this, the executive holds 5,189.88 phantom units. The report also lists multiple employee stock options with exercise prices between $51.89 and $77.72 and expiration dates ranging from 01/25/2028 to 01/27/2035, along with restricted stock units that vest in three annual installments and convert into common shares on a 1‑for‑1 basis.
H.B. Fuller Company director Form 4 filing reports equity-based compensation. On 11/28/2025, the director acquired 471.86 stock units at a conversion price of $0.0000, which convert into H.B. Fuller common stock on a 1-for-1 basis. These units are credited under the Directors' Deferred Compensation Plan and are generally converted into common shares upon retirement, death, disability or other specified events under the plan.
Following this transaction, the director beneficially owned 9,996.65 stock units directly under the plan, which amount includes units added through a dividend equivalent feature. The filing also shows 1,351.511 restricted stock units, which convert into common stock on a 1-for-1 basis and include additional units earned via dividend equivalents, with an exercisable and expiration date of 01/24/2026.
H.B. Fuller Company director reports acquisition of deferred stock units. A board member of H.B. Fuller Company (ticker FUL) filed a Form 4 reporting a transaction dated 11/28/2025. The insider now directly holds 2,343 shares of common stock.
In addition, the director acquired 1,132.46 stock units under a Directors' Deferred Compensation Plan at a stated derivative security price of $58.28. These stock units convert into common shares on a 1-for-1 basis and will be settled in common stock upon retirement, death, disability or other specified events defined in the plan, subject to required holding periods. Following this transaction, the director beneficially owns 19,764.51 stock units, which include units accumulated through a dividend equivalent feature of the plan.
H.B. Fuller Company (FUL) director reported changes in equity holdings on a Form 4 dated for a transaction on 11/28/2025. The director now directly holds 1,343 shares of common stock.
In addition, the director acquired 471.86 stock units under the Directors' Deferred Compensation Plan at a conversion or exercise price of $0.0000, marked as an acquisition. These stock units convert into common shares on a 1-for-1 basis and will be delivered upon retirement, death, disability, or other specified events under the plan, subject to applicable holding periods.
Following this transaction, the director beneficially owns 13,917.35 stock units as derivative securities, which include units accumulated through a dividend equivalent feature of the plan.
H.B. Fuller Company director reports deferred stock unit activity. A company director filed a Form 4 showing changes in their equity holdings as of 11/28/2025. Following the reported non-derivative transaction, the director beneficially owned 1,347.1 shares of H.B. Fuller common stock held directly.
The filing also reports an acquisition of 589.82 stock units at a conversion or exercise price of $0.0000 per unit, with each unit convertible into one share of common stock. These units are part of a deferred compensation arrangement and convert into common shares upon retirement, death, disability, or other specified events under the plan. After this transaction, the director held 76,681.06 stock units directly, including units accumulated through a dividend equivalent feature.
H.B. Fuller director reports additional deferred stock units and current holdings. A company director filed a Form 4 for a transaction dated 11/28/2025 involving stock units under the Directors' Deferred Compensation Plan. The filing shows an acquisition of 377.49 stock units with a conversion or exercise price of $0.0000 and an underlying 377.49 shares of common stock, with a reference price of $58.28. These units convert into common stock on a 1-for-1 basis and will be issued upon retirement, death, disability or other specified events under the plan, subject to legal holding periods. After this transaction, the reporting person beneficially owns 29,290.16 stock units directly, as well as 1,351 shares of H.B. Fuller common stock directly.
H.B. Fuller Company (FUL) Executive Vice President and Chief Financial Officer filed a Form 4 reporting equity holdings and a new derivative award. As of the reported transaction on 11/21/2025, the insider beneficially owned 54,646 shares of H.B. Fuller common stock. The filing shows an acquisition of 164.38 phantom units, which are derivative securities that convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan and related terms, bringing total phantom units beneficially owned to 27,527.56 units.
The report also lists multiple employee stock options with exercise prices ranging from $45.05 to $77.72 per share, with expiration dates between 01/24/2027 and 01/27/2035, some of which are fully vested and others vesting in three annual installments of 33%, 33%, and 34%. In addition, the officer holds restricted stock units that convert to common stock on a 1-for-1 basis and vest over three years, with amounts such as 1,302.35, 2,852.64, and 4,370.58 units, including units acquired through dividend equivalent reinvestment.
H.B. Fuller Company (FUL) senior vice president of international growth filed a Form 4 reporting updated ownership of company equity on 11/21/2025. The filing shows 22,316.23 shares of common stock held directly, a balance that includes shares accumulated through a dividend reinvestment plan. It also reports the acquisition of 37.81 phantom units at an exercise price of $0.0000, which convert into common stock on a 1-for-1 basis under a deferred compensation plan, bringing total phantom units beneficially owned to 5,152.6.
The report details multiple employee stock options to buy H.B. Fuller common stock at exercise prices ranging from $51.89 to $77.72, with expiration dates between 01/25/2028 and 01/27/2035. Some of these options are already 100% vested, while others vest in three annual installments of 33%, 33%, and 34%. The filing also lists restricted stock units that convert into common stock on a 1-for-1 basis, vesting over three annual installments and increasing through dividend equivalent reinvestment features.
H.B. Fuller (FUL) reported an insider transaction by its Executive Vice President, Business Transformation. On 11/13/2025, the officer exercised 9,546 stock options at $33.38 per share and sold 7,075 shares at a $58.3771 weighted average price. The sale price range was $58.02–$58.6850. Following these transactions, the officer beneficially owned 9,441 common shares directly.
H.B. Fuller (FUL) Executive VP and CFO reported insider activity on a Form 4. On 11/07/2025, the officer acquired 162.88 phantom units tied to common stock at a reference price of $57.87. Following this, the officer beneficially owns 27,363.18 phantom units.
The filing also shows 54,646 shares of common stock held directly after the reported activity. In addition, the officer holds multiple employee stock options and restricted stock units with stated vesting and expiration terms, reflecting ongoing equity-based compensation.
H.B. Fuller (FUL) reported insider activity by its Sr. VP, International Growth. On 11/07/2025, the officer acquired 37.47 phantom units (Transaction Code A), which convert into common stock on a 1-for-1 basis under the company plan.
Following the reported transactions, the officer beneficially owned 22,316.23 shares of common stock directly and 5,114.79 derivative units. The filing also lists outstanding employee stock options, including 21,834 options at $53.57 expiring 01/25/2028 and 19,520 options at $51.89 expiring 01/27/2031, alongside restricted stock units that vest in three annual installments beginning on their stated dates.
H.B. Fuller (FUL) Executive VP and CFO reported insider transactions. On 10/27/2025, the officer exercised 16,672 employee stock options at a $43.48 exercise price (code M) and sold 14,222 shares at a $60.3125 weighted average price (code S). After these trades, direct beneficial ownership stood at 54,646 common shares.
Separately, on 10/24/2025, the officer acquired 153.29 phantom units (code A), which convert into common stock on a 1‑for‑1 basis under the Key Employee Deferred Compensation Plan. The filing lists additional vested and time‑based option and RSU awards with stated expiration and vesting schedules.
Sale prices ranged from $60.02 to $60.9350, and the reporting person will provide full pricing details upon request.
H.B. Fuller (FUL) senior vice president, International Growth, filed a Form 4 reporting an equity award update. On 10/24/2025, the reporting person acquired 35.26 phantom units at $61.49 per unit. Per the plan, these units convert into common stock on a 1-for-1 basis and may settle upon specified termination events. Following the transaction, the person beneficially owned 5,056.78 phantom units directly.
The filing shows 22,316.23 shares of common stock beneficially owned directly. It also lists employee stock options for 19,520, 21,834, 11,636, 10,831, 10,730 and 9,928 shares with exercise prices between $51.89 and $77.72, with stated vesting schedules and expirations from 01/25/2028 to 01/27/2035. Restricted stock units of 623.89, 1,139.13 and 1,918.46 convert 1-for-1 into common stock and vest in three annual installments beginning on the dates shown.
H.B. Fuller (FUL) reported insider equity activity for its Executive VP and CFO on a Form 4. On 10/10/2025, the officer acquired 165.1 phantom units (1-for-1 into common stock), bringing total phantom units beneficially owned to 26,936.83, including amounts from a dividend equivalent feature. Following the reported transactions, the officer directly owned 52,196 shares of common stock.
The filing also lists multiple employee stock options with exercise prices between $43.48 and $77.72 and various expiration dates, plus restricted stock units that vest in three annual installments beginning on their stated grant dates.
H.B. Fuller (FUL) senior officer (Sr. VP, International Growth) reported insider activity on 10/10/2025. The filing shows an acquisition of 37.98 phantom units, which convert into common stock on a 1‑for‑1 basis.
Following the reported transactions, the officer beneficially owned 22,316.23 shares of common stock (direct). Derivative holdings included 5,021.52 phantom units after the update, plus various employee stock options and restricted stock units with stated exercise prices, vesting schedules, and expirations as disclosed.
Insider transactions by Gregory O. Ogunsanya, Sr. VP, General Counsel and Corporate Secretary, show multiple equity award activities on 10/04/2025. He received 3,701 restricted stock units (RSUs) and 191 RSUs that vested, and had withholding for taxes of 191 and 3,701 shares respectively. The filings report acquisitions (code M) of 3,701 and 191 shares at an effective price of $59.28 per share and dispositions (code F) for tax withholding of 60 and 1,134 shares at the same price, leaving beneficial ownership in common stock at 6,567, 6,758, 6,698, and 5,564 across separate reported lines.
Derivatives disclosed include vested and outstanding employee stock options totaling 22,594 underlying shares across three option grants with exercise prices of $64.28, $70.28, and $77.72, plus additional RSU tranches and dividend-equivalent reinvestments. Vesting schedules are described in the explanations with multi-year installments starting on the stated vesting dates.
James J. East, Executive Vice President of Fuller H. B. Co. (ticker FUL), reported a purchase of 31 shares of Fuller common stock on 09/26/2025 at a price of $58.62 per share. After the transaction, Mr. East beneficially owned 2,822 shares directly and 105.34 shares indirectly through a 401(k) plan. The filing also discloses his outstanding equity awards: employee stock options exercisable into a total of 39,834 shares across four grants, phantom units converting into 4,102.62 shares, and restricted stock units convertible into 4,776.98 shares on various vesting schedules and exercise/expiration dates between 2026 and 2035. Dividend-equivalent features increased reported amounts for some units and RSUs.
Fuller H. B. Co. (FUL) Form 4: John J. Corkrean, Executive Vice President and CFO, reported insider activity dated 09/26/2025. The filing shows a disposition of 52,196 shares of common stock reported in Table I. Table II records derivative and equity-based holdings: acquisition of 162.12 phantom units that convert 1-for-1 into common stock, and a schedule of existing employee stock options and restricted stock units that the reporting person beneficially owns following the transactions (optioned shares range from 16,672 to 48,309 per grant; multiple RSU grants totaling 1,297.11, 2,841.16 and 4,352.99 shares). The form is signed by an attorney-in-fact on 09/29/2025. The filing documents routine exercised/vested equity awards and a reported share sale; no earnings or forward-looking guidance is included.
Heather Campe, Senior Vice President, International Growth at Fuller H.B. Company (FUL), reported changes in her beneficial ownership on Form 4 covering transactions dated 09/26/2025. The filing shows a disposition of 22,316.23 shares of common stock (noted to include shares from a dividend reinvestment plan). The report also lists multiple outstanding employee stock options across several grant dates and strike prices totaling 83,479 option shares across six option grants, along with phantom units and restricted stock units that convert 1-for-1 into common stock (RSU balances of 623.89, 1,139.13, and 1,918.46). The form was signed by an attorney-in-fact on behalf of the reporting person on 09/29/2025.